Loading…

UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization

Hypoxia-inducible factor 1 (HIF-1) has been recognized as an important mediator of the reprogramming of carbohydrate metabolic pathways from oxidative phosphorylation to accelerated glycolysis. Although this reprogramming has been associated with the antioxidant and radioresistant properties of canc...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2017-07, Vol.7 (1), p.6879-9, Article 6879
Main Authors: Nakashima, Ryota, Goto, Yoko, Koyasu, Sho, Kobayashi, Minoru, Morinibu, Akiyo, Yoshimura, Michio, Hiraoka, Masahiro, Hammond, Ester M., Harada, Hiroshi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c650t-2c897ba9b26c8ac414440a0a853323e2bab6aea66f1dd9470b8a84ed43f1cf9c3
cites cdi_FETCH-LOGICAL-c650t-2c897ba9b26c8ac414440a0a853323e2bab6aea66f1dd9470b8a84ed43f1cf9c3
container_end_page 9
container_issue 1
container_start_page 6879
container_title Scientific reports
container_volume 7
creator Nakashima, Ryota
Goto, Yoko
Koyasu, Sho
Kobayashi, Minoru
Morinibu, Akiyo
Yoshimura, Michio
Hiraoka, Masahiro
Hammond, Ester M.
Harada, Hiroshi
description Hypoxia-inducible factor 1 (HIF-1) has been recognized as an important mediator of the reprogramming of carbohydrate metabolic pathways from oxidative phosphorylation to accelerated glycolysis. Although this reprogramming has been associated with the antioxidant and radioresistant properties of cancer cells, gene networks triggering the HIF-1-mediated reprogramming and molecular mechanisms linking the reprogramming with radioresistance remain to be determined. Here, we show that Ubiquitin C-terminal hydrolase-L1 (UCHL1), which we previously identified as a novel HIF-1 activator, increased the radioresistance of cancer cells by producing an antioxidant, reduced glutathione (GSH), through HIF-1-mediated metabolic reprogramming. A luciferase assay to monitor HIF-1 activity demonstrated that the overexpression of UCHL1, but not its deubiquitination activity-deficient mutant (UCHL1 C90S), upregulated HIF-1 activity by stabilizing the regulatory subunit of HIF-1 (HIF-1α) in a murine breast cancer cell line, EMT6. UCHL1 overexpression induced the reprogramming of carbohydrate metabolism and increased NADPH levels in a pentose phosphate pathway (PPP)-dependent manner. The UCHL1-mediated reprogramming elevated intracellular GSH levels, and consequently induced a radioresistant phenotype in a HIF-1-dependent manner. The pharmacological inhibition of PPP canceled the UCHL1-mediated radioresistance. These results collectively suggest that cancer cells acquire antioxidant and radioresistant phenotypes through UCHL1-HIF-1-mediated metabolic reprogramming including the activation of PPP and provide a rational basis for targeting this gene network for radiosensitization.
doi_str_mv 10.1038/s41598-017-06605-1
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0eb813fe8b2c4d88992eb98d2a5ae043</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_0eb813fe8b2c4d88992eb98d2a5ae043</doaj_id><sourcerecordid>1925272257</sourcerecordid><originalsourceid>FETCH-LOGICAL-c650t-2c897ba9b26c8ac414440a0a853323e2bab6aea66f1dd9470b8a84ed43f1cf9c3</originalsourceid><addsrcrecordid>eNp1kk1rGzEQhpfS0oQ0f6CHIuill031uStdCsU0tcHQS3MWs9pZR8ZebSVtSfrrK8dJcAoVAn2982g0eqvqPaNXjAr9OUmmjK4pa2vaNFTV7FV1zqlUNRecvz6Zn1WXKW1paYobyczb6ozrtmFleV7tbxbLNauXq-uaEbjzqd5j7yFjT2DMPtz5voxkimHCmO9JGIiD0WEkDne7RKB0km8xwoRz9o5kiBvMZAiRROh9SDgmn_0fKLDxXfVmgF3Cy8fxorq5_vZzsazXP76vFl_XtWsUzTV32rQdmI43ToOTTEpJgYJWQnCBvIOuAYSmGVjfG9nSToOW2EsxMDcYJy6q1ZHbB9jaKfo9xHsbwNuHjRA3FmLJdoeWYqeZGFB33Mlea2M4dkb3HBQglaKwvhxZ09yV2jgcc4TdC-jLk9Hf2k34bZUSLWemAD49AmL4NWPKdu_ToXowYpiTZYYr3nKu2iL9-I90G-Y4llIVlWpZ-TdzUPGjysWQUsThORlG7cEc9mgOW8xhH8xhWQn6cPqM55AnKxSBOApSORo3GE_u_j_2L1zCxec</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1957128797</pqid></control><display><type>article</type><title>UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization</title><source>Publicly Available Content Database</source><source>Full-Text Journals in Chemistry (Open access)</source><source>PubMed Central</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Nakashima, Ryota ; Goto, Yoko ; Koyasu, Sho ; Kobayashi, Minoru ; Morinibu, Akiyo ; Yoshimura, Michio ; Hiraoka, Masahiro ; Hammond, Ester M. ; Harada, Hiroshi</creator><creatorcontrib>Nakashima, Ryota ; Goto, Yoko ; Koyasu, Sho ; Kobayashi, Minoru ; Morinibu, Akiyo ; Yoshimura, Michio ; Hiraoka, Masahiro ; Hammond, Ester M. ; Harada, Hiroshi</creatorcontrib><description>Hypoxia-inducible factor 1 (HIF-1) has been recognized as an important mediator of the reprogramming of carbohydrate metabolic pathways from oxidative phosphorylation to accelerated glycolysis. Although this reprogramming has been associated with the antioxidant and radioresistant properties of cancer cells, gene networks triggering the HIF-1-mediated reprogramming and molecular mechanisms linking the reprogramming with radioresistance remain to be determined. Here, we show that Ubiquitin C-terminal hydrolase-L1 (UCHL1), which we previously identified as a novel HIF-1 activator, increased the radioresistance of cancer cells by producing an antioxidant, reduced glutathione (GSH), through HIF-1-mediated metabolic reprogramming. A luciferase assay to monitor HIF-1 activity demonstrated that the overexpression of UCHL1, but not its deubiquitination activity-deficient mutant (UCHL1 C90S), upregulated HIF-1 activity by stabilizing the regulatory subunit of HIF-1 (HIF-1α) in a murine breast cancer cell line, EMT6. UCHL1 overexpression induced the reprogramming of carbohydrate metabolism and increased NADPH levels in a pentose phosphate pathway (PPP)-dependent manner. The UCHL1-mediated reprogramming elevated intracellular GSH levels, and consequently induced a radioresistant phenotype in a HIF-1-dependent manner. The pharmacological inhibition of PPP canceled the UCHL1-mediated radioresistance. These results collectively suggest that cancer cells acquire antioxidant and radioresistant phenotypes through UCHL1-HIF-1-mediated metabolic reprogramming including the activation of PPP and provide a rational basis for targeting this gene network for radiosensitization.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-017-06605-1</identifier><identifier>PMID: 28761052</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>13/106 ; 13/109 ; 13/89 ; 38/109 ; 692/4028/67/1059/485 ; 692/4028/67/395 ; Animals ; Antioxidants ; Breast cancer ; Breast Neoplasms - metabolism ; Breast Neoplasms - radiotherapy ; Cancer ; Carbohydrate Metabolism ; Deficient mutant ; Female ; Glutathione ; Glutathione - metabolism ; Glycolysis ; HEK293 Cells ; HeLa Cells ; Humanities and Social Sciences ; Humans ; Hydrolase ; Hypoxia ; Hypoxia-inducible factor 1 ; Hypoxia-Inducible Factor 1, alpha Subunit - metabolism ; Hypoxia-inducible factors ; Metabolic pathways ; Metabolic rate ; Metabolism ; Mice ; Molecular modelling ; multidisciplinary ; NADP ; Oxidative phosphorylation ; Pentose phosphate pathway ; Phosphorylation ; Radiation Tolerance ; Radioresistance ; Radiosensitization ; Science ; Science (multidisciplinary) ; Ubiquitin ; Ubiquitin thiolesterase ; Ubiquitin Thiolesterase - metabolism ; X-Rays</subject><ispartof>Scientific reports, 2017-07, Vol.7 (1), p.6879-9, Article 6879</ispartof><rights>The Author(s) 2017</rights><rights>2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c650t-2c897ba9b26c8ac414440a0a853323e2bab6aea66f1dd9470b8a84ed43f1cf9c3</citedby><cites>FETCH-LOGICAL-c650t-2c897ba9b26c8ac414440a0a853323e2bab6aea66f1dd9470b8a84ed43f1cf9c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1957128797/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1957128797?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,37012,44589,53790,53792,74897</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28761052$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nakashima, Ryota</creatorcontrib><creatorcontrib>Goto, Yoko</creatorcontrib><creatorcontrib>Koyasu, Sho</creatorcontrib><creatorcontrib>Kobayashi, Minoru</creatorcontrib><creatorcontrib>Morinibu, Akiyo</creatorcontrib><creatorcontrib>Yoshimura, Michio</creatorcontrib><creatorcontrib>Hiraoka, Masahiro</creatorcontrib><creatorcontrib>Hammond, Ester M.</creatorcontrib><creatorcontrib>Harada, Hiroshi</creatorcontrib><title>UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>Hypoxia-inducible factor 1 (HIF-1) has been recognized as an important mediator of the reprogramming of carbohydrate metabolic pathways from oxidative phosphorylation to accelerated glycolysis. Although this reprogramming has been associated with the antioxidant and radioresistant properties of cancer cells, gene networks triggering the HIF-1-mediated reprogramming and molecular mechanisms linking the reprogramming with radioresistance remain to be determined. Here, we show that Ubiquitin C-terminal hydrolase-L1 (UCHL1), which we previously identified as a novel HIF-1 activator, increased the radioresistance of cancer cells by producing an antioxidant, reduced glutathione (GSH), through HIF-1-mediated metabolic reprogramming. A luciferase assay to monitor HIF-1 activity demonstrated that the overexpression of UCHL1, but not its deubiquitination activity-deficient mutant (UCHL1 C90S), upregulated HIF-1 activity by stabilizing the regulatory subunit of HIF-1 (HIF-1α) in a murine breast cancer cell line, EMT6. UCHL1 overexpression induced the reprogramming of carbohydrate metabolism and increased NADPH levels in a pentose phosphate pathway (PPP)-dependent manner. The UCHL1-mediated reprogramming elevated intracellular GSH levels, and consequently induced a radioresistant phenotype in a HIF-1-dependent manner. The pharmacological inhibition of PPP canceled the UCHL1-mediated radioresistance. These results collectively suggest that cancer cells acquire antioxidant and radioresistant phenotypes through UCHL1-HIF-1-mediated metabolic reprogramming including the activation of PPP and provide a rational basis for targeting this gene network for radiosensitization.</description><subject>13/106</subject><subject>13/109</subject><subject>13/89</subject><subject>38/109</subject><subject>692/4028/67/1059/485</subject><subject>692/4028/67/395</subject><subject>Animals</subject><subject>Antioxidants</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - metabolism</subject><subject>Breast Neoplasms - radiotherapy</subject><subject>Cancer</subject><subject>Carbohydrate Metabolism</subject><subject>Deficient mutant</subject><subject>Female</subject><subject>Glutathione</subject><subject>Glutathione - metabolism</subject><subject>Glycolysis</subject><subject>HEK293 Cells</subject><subject>HeLa Cells</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Hydrolase</subject><subject>Hypoxia</subject><subject>Hypoxia-inducible factor 1</subject><subject>Hypoxia-Inducible Factor 1, alpha Subunit - metabolism</subject><subject>Hypoxia-inducible factors</subject><subject>Metabolic pathways</subject><subject>Metabolic rate</subject><subject>Metabolism</subject><subject>Mice</subject><subject>Molecular modelling</subject><subject>multidisciplinary</subject><subject>NADP</subject><subject>Oxidative phosphorylation</subject><subject>Pentose phosphate pathway</subject><subject>Phosphorylation</subject><subject>Radiation Tolerance</subject><subject>Radioresistance</subject><subject>Radiosensitization</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Ubiquitin</subject><subject>Ubiquitin thiolesterase</subject><subject>Ubiquitin Thiolesterase - metabolism</subject><subject>X-Rays</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kk1rGzEQhpfS0oQ0f6CHIuill031uStdCsU0tcHQS3MWs9pZR8ZebSVtSfrrK8dJcAoVAn2982g0eqvqPaNXjAr9OUmmjK4pa2vaNFTV7FV1zqlUNRecvz6Zn1WXKW1paYobyczb6ozrtmFleV7tbxbLNauXq-uaEbjzqd5j7yFjT2DMPtz5voxkimHCmO9JGIiD0WEkDne7RKB0km8xwoRz9o5kiBvMZAiRROh9SDgmn_0fKLDxXfVmgF3Cy8fxorq5_vZzsazXP76vFl_XtWsUzTV32rQdmI43ToOTTEpJgYJWQnCBvIOuAYSmGVjfG9nSToOW2EsxMDcYJy6q1ZHbB9jaKfo9xHsbwNuHjRA3FmLJdoeWYqeZGFB33Mlea2M4dkb3HBQglaKwvhxZ09yV2jgcc4TdC-jLk9Hf2k34bZUSLWemAD49AmL4NWPKdu_ToXowYpiTZYYr3nKu2iL9-I90G-Y4llIVlWpZ-TdzUPGjysWQUsThORlG7cEc9mgOW8xhH8xhWQn6cPqM55AnKxSBOApSORo3GE_u_j_2L1zCxec</recordid><startdate>20170731</startdate><enddate>20170731</enddate><creator>Nakashima, Ryota</creator><creator>Goto, Yoko</creator><creator>Koyasu, Sho</creator><creator>Kobayashi, Minoru</creator><creator>Morinibu, Akiyo</creator><creator>Yoshimura, Michio</creator><creator>Hiraoka, Masahiro</creator><creator>Hammond, Ester M.</creator><creator>Harada, Hiroshi</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><general>Nature Portfolio</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20170731</creationdate><title>UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization</title><author>Nakashima, Ryota ; Goto, Yoko ; Koyasu, Sho ; Kobayashi, Minoru ; Morinibu, Akiyo ; Yoshimura, Michio ; Hiraoka, Masahiro ; Hammond, Ester M. ; Harada, Hiroshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c650t-2c897ba9b26c8ac414440a0a853323e2bab6aea66f1dd9470b8a84ed43f1cf9c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>13/106</topic><topic>13/109</topic><topic>13/89</topic><topic>38/109</topic><topic>692/4028/67/1059/485</topic><topic>692/4028/67/395</topic><topic>Animals</topic><topic>Antioxidants</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - metabolism</topic><topic>Breast Neoplasms - radiotherapy</topic><topic>Cancer</topic><topic>Carbohydrate Metabolism</topic><topic>Deficient mutant</topic><topic>Female</topic><topic>Glutathione</topic><topic>Glutathione - metabolism</topic><topic>Glycolysis</topic><topic>HEK293 Cells</topic><topic>HeLa Cells</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Hydrolase</topic><topic>Hypoxia</topic><topic>Hypoxia-inducible factor 1</topic><topic>Hypoxia-Inducible Factor 1, alpha Subunit - metabolism</topic><topic>Hypoxia-inducible factors</topic><topic>Metabolic pathways</topic><topic>Metabolic rate</topic><topic>Metabolism</topic><topic>Mice</topic><topic>Molecular modelling</topic><topic>multidisciplinary</topic><topic>NADP</topic><topic>Oxidative phosphorylation</topic><topic>Pentose phosphate pathway</topic><topic>Phosphorylation</topic><topic>Radiation Tolerance</topic><topic>Radioresistance</topic><topic>Radiosensitization</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Ubiquitin</topic><topic>Ubiquitin thiolesterase</topic><topic>Ubiquitin Thiolesterase - metabolism</topic><topic>X-Rays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nakashima, Ryota</creatorcontrib><creatorcontrib>Goto, Yoko</creatorcontrib><creatorcontrib>Koyasu, Sho</creatorcontrib><creatorcontrib>Kobayashi, Minoru</creatorcontrib><creatorcontrib>Morinibu, Akiyo</creatorcontrib><creatorcontrib>Yoshimura, Michio</creatorcontrib><creatorcontrib>Hiraoka, Masahiro</creatorcontrib><creatorcontrib>Hammond, Ester M.</creatorcontrib><creatorcontrib>Harada, Hiroshi</creatorcontrib><collection>SpringerOpen</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nakashima, Ryota</au><au>Goto, Yoko</au><au>Koyasu, Sho</au><au>Kobayashi, Minoru</au><au>Morinibu, Akiyo</au><au>Yoshimura, Michio</au><au>Hiraoka, Masahiro</au><au>Hammond, Ester M.</au><au>Harada, Hiroshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2017-07-31</date><risdate>2017</risdate><volume>7</volume><issue>1</issue><spage>6879</spage><epage>9</epage><pages>6879-9</pages><artnum>6879</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Hypoxia-inducible factor 1 (HIF-1) has been recognized as an important mediator of the reprogramming of carbohydrate metabolic pathways from oxidative phosphorylation to accelerated glycolysis. Although this reprogramming has been associated with the antioxidant and radioresistant properties of cancer cells, gene networks triggering the HIF-1-mediated reprogramming and molecular mechanisms linking the reprogramming with radioresistance remain to be determined. Here, we show that Ubiquitin C-terminal hydrolase-L1 (UCHL1), which we previously identified as a novel HIF-1 activator, increased the radioresistance of cancer cells by producing an antioxidant, reduced glutathione (GSH), through HIF-1-mediated metabolic reprogramming. A luciferase assay to monitor HIF-1 activity demonstrated that the overexpression of UCHL1, but not its deubiquitination activity-deficient mutant (UCHL1 C90S), upregulated HIF-1 activity by stabilizing the regulatory subunit of HIF-1 (HIF-1α) in a murine breast cancer cell line, EMT6. UCHL1 overexpression induced the reprogramming of carbohydrate metabolism and increased NADPH levels in a pentose phosphate pathway (PPP)-dependent manner. The UCHL1-mediated reprogramming elevated intracellular GSH levels, and consequently induced a radioresistant phenotype in a HIF-1-dependent manner. The pharmacological inhibition of PPP canceled the UCHL1-mediated radioresistance. These results collectively suggest that cancer cells acquire antioxidant and radioresistant phenotypes through UCHL1-HIF-1-mediated metabolic reprogramming including the activation of PPP and provide a rational basis for targeting this gene network for radiosensitization.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>28761052</pmid><doi>10.1038/s41598-017-06605-1</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-2322
ispartof Scientific reports, 2017-07, Vol.7 (1), p.6879-9, Article 6879
issn 2045-2322
2045-2322
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_0eb813fe8b2c4d88992eb98d2a5ae043
source Publicly Available Content Database; Full-Text Journals in Chemistry (Open access); PubMed Central; Springer Nature - nature.com Journals - Fully Open Access
subjects 13/106
13/109
13/89
38/109
692/4028/67/1059/485
692/4028/67/395
Animals
Antioxidants
Breast cancer
Breast Neoplasms - metabolism
Breast Neoplasms - radiotherapy
Cancer
Carbohydrate Metabolism
Deficient mutant
Female
Glutathione
Glutathione - metabolism
Glycolysis
HEK293 Cells
HeLa Cells
Humanities and Social Sciences
Humans
Hydrolase
Hypoxia
Hypoxia-inducible factor 1
Hypoxia-Inducible Factor 1, alpha Subunit - metabolism
Hypoxia-inducible factors
Metabolic pathways
Metabolic rate
Metabolism
Mice
Molecular modelling
multidisciplinary
NADP
Oxidative phosphorylation
Pentose phosphate pathway
Phosphorylation
Radiation Tolerance
Radioresistance
Radiosensitization
Science
Science (multidisciplinary)
Ubiquitin
Ubiquitin thiolesterase
Ubiquitin Thiolesterase - metabolism
X-Rays
title UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T22%3A01%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=UCHL1-HIF-1%20axis-mediated%20antioxidant%20property%20of%20cancer%20cells%20as%20a%20therapeutic%20target%20for%20radiosensitization&rft.jtitle=Scientific%20reports&rft.au=Nakashima,%20Ryota&rft.date=2017-07-31&rft.volume=7&rft.issue=1&rft.spage=6879&rft.epage=9&rft.pages=6879-9&rft.artnum=6879&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-017-06605-1&rft_dat=%3Cproquest_doaj_%3E1925272257%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c650t-2c897ba9b26c8ac414440a0a853323e2bab6aea66f1dd9470b8a84ed43f1cf9c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1957128797&rft_id=info:pmid/28761052&rfr_iscdi=true